Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment completed in phase III trial of Aptosyn/Taxotere in NSCLC

March 12, 2003

Velcade NDA granted priority review

March 12, 2003

Novel antitumor ecteinascidins reported by Spanish research team

March 12, 2003

Gemin X claims novel compounds for cancer, viral infections and autoimmune diseases

March 12, 2003

Evaluation of antiangiogenic effects of BMS-275291 with a novel dermal wound assay

March 11, 2003

Dolastatin 10 derivatives with antitumor activity covered by Roche patent

March 11, 2003

Mechanism underlying antitumor/antiangiogenic effects of Panzem

March 10, 2003

Bisphosphonate has antitumor and apoptosis-inducing effects in hematopoietic tumor cells

March 10, 2003

New antiangiogenic bisphosphonates: preparation and uses

March 10, 2003

Italian researchers prepare and test antitumor gold complexes

March 10, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...